Ignite Creation Date:
2024-05-06 @ 3:10 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02228421
Status:
TERMINATED
Last Update Posted:
2020-03-11
First Post:
2014-08-27
Brief Title:
Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
Sponsor:
PeriPharm
Organization:
PeriPharm
Organization Data
Organization:
PeriPharm
Class:
OTHER
Study ID:
PMPC-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PeriPharm
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Personalized Medicine Partnership for Cancer | OTHER |
| Jewish General Hospital | OTHER |